verified SJR 5,282 · Q1 • database Scopus / SJR & Web of Science indexed

Bi Monthly

United Kingdom · Churchill Livingstone

workspace_premium Q1 — Infectious Diseases lock_open Open Access Unclaimed

Drug Resistance Updates

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical...

ISSN: 1368-7646

Editorial: Churchill Livingstone

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

5,282 Q1

H-index 139

Tasa de Aceptación pie_chart

23% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

3.072 € Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

5,282

H-index

139

Docs (year)

102

Docs 3y

123

Total refs

9024

Cites 3y

2883

Citable 3y

121

Cites/Doc 2y

21.83

Ref/Doc

88.47

Immediate OA

3072 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Liposomal formulations of anticancer drugs: selectivity and effectiveness

Workshop on ABC Transporters and Human Diseases

Vascular remodeling and clinical resistance to antiangiogenic cancer therapy

The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates

The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer

The apicoplast as an antimalarial drug target

The 90th Annual Meeting of the American Association for Cancer Research (AACR) Philadelphia, USA, 10-14 April 1999

The TRAIL to an anti-cancer agent

p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53

New developments: Chloroquine-resistance in Plasmodium falciparum

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use

SHOW MORE ARTICLES

Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces

Leishmaniasis: drugs in the clinic, resistance and new developments

Invasive Candida infections in the neonate

Infectious disease 2000: drug resistance and new drugs

Immunotherapy for invasive fungal infections: from bench to bedside

Hypoxic cytotoxic agents: a new approach to cancer chemotherapy

Future perspectives for the development of P-glycoprotein modulators

Erratum to "Strategies to target HER2/neu overexpression for cancer therapy"

Erratum

Effects of HER-2/neu on chemosensitivity of tumor cells

EDITORIAL

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.